Literature DB >> 29807688

Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1α, MIP-1β, and RANTES.

Veronica Obregon-Perko1, Vida L Hodara2, Laura M Parodi3, Luis D Giavedoni4.   

Abstract

Simian immunodeficiency virus (SIV) infection in rhesus macaques is often characterized by high viremia and CD4 T cell depletion. By contrast, SIV infection in African nonhuman primate natural hosts is typically nonpathogenic despite active viral replication. Baboons are abundant in Africa and have a geographical distribution that overlaps with natural hosts, but they do not harbor SIVs. Previous work has demonstrated baboons are resistant to chronic SIV infection and/or disease in vivo but the underlying mechanisms remain unknown. Using in vitro SIVmac infections, we sought to identify SIV restriction factors in baboons by comparing observations to the pathogenic rhesus macaque model. SIVmac replicated in baboon PBMC but had delayed kinetics compared to rhesus PBMC. However, SIVmac replication in baboon and rhesus isolated CD4 cells were similar to the kinetics seen for rhesus PBMC, demonstrating intracellular restriction factors do not play a strong role in baboon inhibition of SIVmac replication. Here, we show CD8 T cells contribute to the innate SIV-suppressive activity seen in naïve baboon PBMC. As one mechanism of restriction, we identified higher production of MIP-1α, MIP-1β, and RANTES by baboon PBMC. Contact between CD4 and CD8 T cells resulted in maximum production of these chemokines and suppression of viral replication, whereas neutralization of CCR5-binding chemokines in baboon PBMC increased viral loads. Our studies indicate baboon natural restriction of SIVmac replication is largely dependent on CD4-extrinsinc mechanisms mediated, in part, by CD8 T cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; Baboon; CCR5; Chemokine; Cytokine

Mesh:

Substances:

Year:  2018        PMID: 29807688      PMCID: PMC6261791          DOI: 10.1016/j.cyto.2018.05.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  68 in total

1.  Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.

Authors:  B L Levine; J D Mosca; J L Riley; R G Carroll; M T Vahey; L L Jagodzinski; K F Wagner; D L Mayers; D S Burke; O S Weislow; D C St Louis; C H June
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

2.  Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo.

Authors:  L Margolis; S Glushakova; C Chougnet; G Shearer; P Markham; M Robert-Guroff; R Benveniste; C J Miller; M Cranage; V Hirsch; G Franchini
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

3.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Phenotypic changes associated with advancing gestation in maternal and fetal baboon lymphocytes.

Authors:  Luis D Giavedoni; Natalia Schlabritz-Loutsevitch; Vida L Hodara; Laura M Parodi; Gene B Hubbard; Donald J Dudley; Thomas J McDonald; Peter W Nathanielsz
Journal:  J Reprod Immunol       Date:  2004-12       Impact factor: 4.054

6.  Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.

Authors:  A E Yeo; A Matsumoto; M Hisada; J W Shih; H J Alter; J J Goedert
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

7.  Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts.

Authors:  Ivona Pandrea; Cristian Apetrei; Shari Gordon; Joseph Barbercheck; Jason Dufour; Rudolf Bohm; Beth Sumpter; Pierre Roques; Preston A Marx; Vanessa M Hirsch; Amitinder Kaur; Andrew A Lackner; Ronald S Veazey; Guido Silvestri
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

8.  In vitro growth characteristics of simian T-lymphotropic virus type III.

Authors:  M Kannagi; J M Yetz; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Authors:  Yoshiko Usami; Yuanfei Wu; Heinrich G Göttlinger
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

10.  APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host.

Authors:  Annabel Krupp; Kevin R McCarthy; Marcel Ooms; Michael Letko; Jennifer S Morgan; Viviana Simon; Welkin E Johnson
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

View more
  3 in total

1.  Silencing integrated SIV proviral DNA with TAR-specific CRISPR tools.

Authors:  Lisa M Smith; Vida L Hodara; Laura M Parodi; Jessica E Callery; Luis D Giavedoni
Journal:  J Med Primatol       Date:  2020-09-09       Impact factor: 0.667

2.  Establishment and characterization of a new human first trimester Trophoblast cell line, AL07.

Authors:  Hong Liu; Liling Wang; Yan Wang; Qian Zhu; Paulomi Aldo; Jiahui Ding; Gil Mor; Aihua Liao
Journal:  Placenta       Date:  2020-08-21       Impact factor: 3.481

3.  Molecular Approaches for the Validation of the Baboon as a Nonhuman Primate Model for the Study of Zika Virus Infection.

Authors:  Emma Mask; Vida L Hodara; Jessica E Callery; Laura M Parodi; Veronica Obregon-Perko; Shigeo Yagi; Jeremy Glenn; Patrice Frost; Elizabeth Clemmons; Jean L Patterson; Laura A Cox; Luis D Giavedoni
Journal:  Front Cell Infect Microbiol       Date:  2022-04-14       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.